Mirum Pharmaceuticals (MIRM) Earnings Date & Reports

A.I. Advisor

published Earnings

MIRM is expected to report earnings to fall 27.23% to -37 cents per share on November 06

Mirum Pharmaceuticals MIRM Stock Earnings Reports

Q3'24

Est.

$-0.38

Q2'24

Missed

by $0.05

Q1'24

Missed

by $0.12

Q4'23

Beat

by $0.24

Q3'23

Beat

by $0.06

The last earnings report on August 07 showed earnings per share of -51 cents, missing the estimate of -46 cents. With 295.35K shares outstanding, the current market capitalization sits at 1.99B.

View a ticker or compare two or three

Compare

MIRM

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For MIRM
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for MIRM (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a biopharmaceutical company. which focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases.

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

950 Tower Lane

Phone

+1 650 667-4085

Employees

264

Web

https://www.mirumpharma.com